Chemoinformaics analysis of Cyclohexane, 1-(1,5-Dimethylhexyl)-4-(4-Methylpentyl)-
Molecular Weight | 280.54 | nRot | 9 |
Heavy Atom Molecular Weight | 240.22 | nRig | 6 |
Exact Molecular Weight | 280.313 | nRing | 1 |
Solubility: LogS | -7.262 | nHRing | 0 |
Solubility: LogP | 8.385 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
Atoms Count | 60 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 0 |
nHetero | 0 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 1 |
No. of Hydrogen atom | 40 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 0 | No. of Arom Bond | 0 |
nHA | 0 | APOL | 60.0717 |
nHD | 0 | BPOL | 40.1283 |
QED | 0.423 |
Synth | 2.73 |
Natural Product Likeliness | 0.699 |
NR-PPAR-gamma | 0.004 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0.022 |
Pgp-sub | 0.053 |
HIA | 0.002 |
CACO-2 | -4.579 |
MDCK | 0.00000888 |
BBB | 0.098 |
PPB | 0.968815 |
VDSS | 3.007 |
FU | 0.0158727 |
CYP1A2-inh | 0.064 |
CYP1A2-sub | 0.216 |
CYP2c19-inh | 0.268 |
CYP2c19-sub | 0.722 |
CYP2c9-inh | 0.188 |
CYP2c9-sub | 0.961 |
CYP2d6-inh | 0.017 |
CYP2d6-sub | 0.027 |
CYP3a4-inh | 0.229 |
CYP3a4-sub | 0.206 |
CL | 6.681 |
T12 | 0.023 |
hERG | 0.12 |
Ames | 0.004 |
ROA | 0.031 |
SkinSen | 0.773 |
Carcinogencity | 0.037 |
EI | 0.966 |
Respiratory | 0.031 |
NR-Aromatase | 0.005 |
Antiviral | No |
Prediction | 0.51374 |